Steve Gillis
VCManaging Director, ARCH Venture Partners
Immunologist founder turned deep biotech investor
Background
Steve Gillis, PhD, is a Managing Director at ARCH Venture Partners, joining as a Venture Partner in 2005 and becoming a Managing Director in 2006. An immunologist by training with over 300 peer-reviewed publications, he co-founded Immunex Corp. (Washington's most successful venture-funded biotech) and Corixa Corp. (acquired by GlaxoSmithKline in 2005). He holds a BA from Williams College and a PhD from Dartmouth College. He currently chairs and leads boards of numerous ARCH portfolio companies in oncology and immunology.
Investment Thesis
Building life science companies at the frontier of immunology, oncology, and cell therapy based on validated mechanisms.
Investment Focus
Stages
Sectors
Based in: Seattle, WA (North America)